FDA

The Department of Pharmaceuticals (DoP) is significantly impacting India’s medical device manufacturing landscape by implementing targeted programs and financial backing for state-driven projects. Dr H G Koshia, Commissioner of the Gujarat Food and Drug Control Administration (FDCA), highlights that Gujarat’s […]

India must focus on innovative drug development, vaccine enhancement, and improving infection control strategies to effectively counter antimicrobial resistance (AMR). From both national and global perspectives, recent advancements in AMR treatment include bacteriophage therapy, nanotechnology, and immunotherapies, among others. According

The overall sales of premium pharmaceutical products such as biopharmaceuticals, intricate generic drugs, and patented medications, among others, produced under the production linked incentive (PLI) framework in the pharmaceuticals sector totaled approximately Rs. 11,853 crore for the first half of

The All India Institute of Medical Sciences (AIIMS), located in New Delhi, has entered into a Memorandum of Understanding (MoU) with Wipro GE Healthcare Pvt Ltd, a global leader in healthcare technology, to launch an AI Health Innovations Hub. This

Beacon Biosignals, a global frontrunner in at-home EEG and AI-enhanced brain health analysis, showcased two scientific posters at the American Epilepsy Society (AES) annual conference. These presentations spotlight innovative research stemming from collaborations with Longboard Pharmaceuticals and UCB, aimed at

Global Commitment to Transforming Patient Lives: FDA to Review Ascendis’ Application for TransCon hGH Ascendis Pharma A/S, a worldwide pharmaceutical leader harnessing the transformative potential of its TransCon technology, strives to emerge as a foremost and cohesive biopharmaceutical entity dedicated

A significant research project indicates a correlation between prolonged exposure to air pollution and elevated risks of venous blood clots. These clots, if not treated, may obstruct blood circulation, causing severe health issues, potentially even fatalities. The study, supported by

Roche has announced that its latest cobas 6800/8800 systems 2.0 have obtained CE certification. This revision significantly boosts operational efficiency in lab settings by optimizing resources, minimizing downtime, consolidating testing options, and increasing capacity. These advancements aim to deliver a

Vir Biotechnology, Inc, an advanced-stage biopharmaceutical firm dedicated to utilizing the immune system for medical breakthroughs in severe infectious diseases and cancer, has announced that the US Food and Drug Administration has granted breakthrough therapy designation to tobevibart and elebsiran,

Bayer has begun a phase I clinical trial for BAY3498264, an investigative oral selective inhibitor targeting Son of Sevenless Homologue 1 (SOS1). The open-label, first-in-human study (NCT06659341) will assess the safety, tolerability, and initial effectiveness of BAY3498264 in combination therapies